Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-gene co-expression plasmid pIRES2-Nrf2-DKK1, preparation method and application thereof

A double-gene, co-expression technology, applied in the field of double-gene co-expression plasmid pIRES2-Nrf2-DKK1 and its preparation, can solve the problems of increased cell number, decreased stem cell activity, and affecting the therapeutic effect of transplanted cells, so as to maintain phenotype and function, ensure continuous proliferation, and maintain a stable effect

Active Publication Date: 2018-04-06
THE THIRD PEOPLES HOSPITAL OF SHENZHEN
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem to be solved by the present invention is to overcome the defects and deficiencies such as the reduction of stem cell activity and the increase of the number of apoptotic cells in the existing stem cell treatment process, thereby affecting the therapeutic effect of transplanted cells on the damaged site, and providing a stem cell Highly expressed double-gene co-expression plasmid pIRES2-Nrf2-DKK1 that can significantly increase the antioxidant, anti-inflammatory, and anti-apoptotic abilities of mesenchymal stem cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-gene co-expression plasmid pIRES2-Nrf2-DKK1, preparation method and application thereof
  • Double-gene co-expression plasmid pIRES2-Nrf2-DKK1, preparation method and application thereof
  • Double-gene co-expression plasmid pIRES2-Nrf2-DKK1, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Example 1 Construction of double-gene co-expression plasmid pIRES2-Nrf2-DKK1

[0058] 1. According to the sequence information of Nrf2 (NM_006164) and DKK-1 (NM_012242) on NCBI, clone the CDS sequences of Nrf2 and DKK-1 genes, the CDS sequences of the Nrf2 and DKK-1 genes are shown as SEQ ID NO: 1~ 2; using the pIRES2-zsGreen vector as the backbone, replace the EGFP gene on the pIRES2-zsGreen vector with the DKK-1 CDS sequence, and then clone the Nrf2 CDS sequence between the SacI and BamHI restriction sites of the pIRES2-DKK1 vector;

[0059] 2. Results

[0060] The full length of the double-gene co-expression plasmid is 7151 bp, wherein the Nrf2 gene sequence is located at the 619th to 2436th position, and the DKK-1 gene sequence is at the 3016th to 3816th position.

Embodiment 2

[0062] When the third-generation adipose-derived mesenchymal stem cells (purchased from Guangzhou Saiye Company) and umbilical cord mesenchymal stem cells (the umbilical cord tissue was obtained from healthy puerpera cesarean section fetuses in the Department of Obstetrics and Gynecology, Shenzhen Third People's Hospital) reached 60% confluence Around the same time, the double-gene co-expression plasmid was transferred into the above two types of cells by Lipofectamine 3000 transfection method. The transfection procedure was carried out according to the manufacturer's instructions. Add 0.1 μg / mL of LPS and 200 μM H 2 o 2 Co-stimulated for 24 hours, in order to avoid external stimulation (LPS+H 2 o 2 ) and cells not transfected with double-gene co-expression plasmids were negative controls. Finally, the cells of each group were collected to detect the levels of indicators related to cell viability, cell apoptosis, and cell oxidation.

[0063] The cell viability was detected...

Embodiment 3

[0069] The mouse model of acute liver injury was established by intraperitoneal injection of Gal and LPS solution in PBS. In the experiment, NOD / SCID male mice were injected with 2x10 6 Pre-transfected hADMSCs and hUCMSCs were used for transplantation therapy. Three days later, mouse serum and liver tissues were collected for follow-up experiments.

[0070] The grouping situation is: Gal+LPS means that the mice were intraperitoneally injected with Gal and LPS at the same time.

[0071] Healthy is a healthy mouse without any treatment.

[0072] Gal+LPS+No stem cell refers to mice that are not injected with stem cells after intraperitoneal injection of Gal and LPS into mice;

[0073] Gal+LPS+Stem cell means that after the intraperitoneal injection of Gal and LPS into the mice, the untreated hADMSCs and hUCMSCs were injected into the tail vein;

[0074] Gal+LPS+Stem cell+Plasmid means that Gal and LPS are injected intraperitoneally into mice, and then hADMSCs and hUCMSCs tran...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a double-gene co-expression plasmid pIRES2-Nrf2-DKK1, a preparation method and an application thereof. The plasmid includes CDS sequences of an original expression vector pIRES2-zs Green, Nrf2 and DKK-1 genes. The plasmid is 7151 bp in overall length and is represented in the SEQ ID No.1; wherein the Nrf2 gene sequence is located from the 619th to the 2436th loci, and the DKK-1 gene sequence is located from the 3016th to the 3816th loci. The double-gene co-expression plasmid can be high-effectively expressed in human adipose mesenchymal stem cells and human umbilical cord mesenchymal stem cells, and can significantly increase anti-oxidizing, anti-inflammation and anti-apoptosis capabilities of the mesenchymal stem cells. In-vivo test proves that by transplanting mesenchymal stem cells transfected by the plasmid can significantly improve liver damage of mice. The plasmid can improve the transplanting treatment effect of the mesenchymal stem cells and has great application prospect.

Description

technical field [0001] The invention belongs to the field of biotechnology. More specifically, it relates to a double-gene co-expression plasmid pIRES2-Nrf2-DKK1 and its preparation method and application. Background technique [0002] In recent years, the proportion of patients with liver injury caused by alcohol and drugs has been increasing. Epidemiological data show that about 3.8% of the world's liver disease deaths are caused by alcoholic cirrhosis caused by drinking. At the same time, about 10% of acute hepatitis cases each year are drug-induced liver injury. These patients with liver damage caused by alcohol or drugs are likely to progress to liver cancer, cirrhosis and liver failure. Currently, doctors mainly use drugs with hepatoprotective effect to conservatively treat patients with mild symptoms of liver damage. However, in critically ill patients, it is still possible to improve their condition only through liver transplantation. Although liver transplantati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85C12N5/10A61K35/28A61P1/16
CPCA61K35/28C12N5/0665C12N5/0667C12N15/85C12N2510/00
Inventor 肖佳刘映霞陈凤何留民
Owner THE THIRD PEOPLES HOSPITAL OF SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com